What is Xinyuan Real Estate Co. LTD. American's earnings per share (EPS)?

Xinyuan Real Estate Co. LTD. American (XIN) reported diluted earnings per share of -$0.45 for fiscal year 2024. This represents a -218.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Xinyuan Real Estate Co. LTD. American (XIN) Financials

XIN

FY2024 annual

Revenue $514.7M -36.1% YoY

Net Income -$51.0M -226.7% YoY

EPS (Diluted) -$0.45 -218.4% YoY

Free Cash Flow $17.6M +106.5% YoY

Source SEC Filings (10-K/10-Q) Latest period FY2024, ended Dec 31, 2024 Reported Apr 29, 2025 Currency USD FYE December

Newest figures come from the 10-K for FY2024, filed Apr 29, 2025. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the XIN SEC filings page.

Xinyuan Real Estate Co. LTD. American (XIN) reported $514.7M in revenue for fiscal year 2024, down 36.1% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI XIN FY2024 2026-08-30

Shrinking sales coexist with recovering operating margins, but heavy financing costs and negative equity still distort earnings quality

Profit and cash changed places: FY2023 reported net income while operating cash flow was negative, whereas FY2024 reported a net loss alongside positive operating cash flow. Because capital spending remained modest relative to operating cash generation, the central issue is earnings conversion and project timing rather than reinvestment intensity.

Revenue contracted from $950M in FY2022 to $515M in FY2024, so the margin recovery did not come from simple volume expansion. Gross margin nevertheless returned to 16.0%, close to FY2023's 16.5%, suggesting mix or cost normalization rather than a scale story.

The balance sheet remains liability-funded: FY2024 liabilities were $5.0B against assets of $5.0B, leaving equity at -$104M. Operating income of $39M was outweighed by interest expense of $117M, showing how financing structure can erase operating profitability at the bottom line.

Financial Health Signals

Financial Health Score 17/100

Scored against operating companies for FY2024. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Xinyuan Real Estate Co. LTD. American's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Xinyuan Real Estate Co. LTD. American has an operating margin of 7.6%, meaning the company retains $8 of operating profit per $100 of revenue. This results in a moderate score of 37/100, indicating healthy but not exceptional operating efficiency. This is up from 6.0% the prior year.

Growth

Xinyuan Real Estate Co. LTD. American's revenue declined 36.1% year-over-year, from $805.0M to $514.7M. This contraction results in a growth score of 3/100.

Leverage

Liquidity

Cash Flow

Xinyuan Real Estate Co. LTD. American's free cash flow margin of 3.4% results in a low score of 8/100. Capital expenditures of $590K absorb a large share of operating cash flow.

Returns

Piotroski F-Score Partial

2/7

Xinyuan Real Estate Co. LTD. American passes 2 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality Mixed

N/A

Xinyuan Real Estate Co. LTD. American reported a net loss of $51.0M while generating $18.2M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk

0.33x

Xinyuan Real Estate Co. LTD. American earns $0.33 in operating income for every $1 of interest expense ($39.0M vs $117.4M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

None of these metrics is reported for Q4 2024.

Cash & Balance Sheet

Cash & Debt

$94.4M

YoY-26.9%

QoQ-26.9%

5Y CAGR-15.0%

Xinyuan Real Estate Co. LTD. American held $94.4M in cash as of Q4 2024; long-term debt is not reported for that period.

Shares Outstanding

113M

YoY+0.5%

QoQ+0.5%

5Y CAGR-5.9%

Xinyuan Real Estate Co. LTD. American had 113M shares outstanding in Q4 2024. This represents an increase of 0.5% from the same quarter a year earlier. Against the prior quarter it is up 0.5%.

Free Cash Flow

Not reported for Q4 2024.

Dividends Per Share

Not reported for Q4 2024.

Margins & Returns

None of these metrics is reported for Q4 2024.

Capital Allocation

None of these metrics is reported for Q4 2024.

XIN Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

XIN quarterly income statement

Metric	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K
Revenue	$514.7M-36.1%	$805.0M-15.3%	$950.0M-38.2%	$1.5B-12.0%	$1.7B-29.7%	$2.5B+12.0%	$2.2B+12.2%	$2.0B+26.6%	$1.6B+34.1%	$1.2B+26.6%	$919.7M+2.5%	$897.7M-1.9%	$914.8M+33.1%	$687.5M+52.8%	$450.0M
Cost of Revenue	$432.2M-35.7%	$672.5M-23.4%	$878.1M-40.2%	$1.5B+1.0%	$1.5B-24.4%	$1.9B+20.0%	$1.6B+5.6%	$1.5B+26.1%	$1.2B+35.0%	$891.3M+31.5%	$677.6M+13.2%	$598.7M-5.7%	$634.8M+30.1%	$487.8M+45.8%	$334.5M
Gross Profit	$82.4M-37.8%	$132.5M+84.1%	$72.0M+5.9%	$67.9M-76.8%	$292.5M-47.8%	$560.3M-9.0%	$615.5M+33.9%	$459.6M+28.4%	$358.0M+31.1%	$273.0M+12.7%	$242.2M-19.0%	$299.0M+6.8%	$280.0M+40.2%	$199.7M+72.9%	$115.5M
SG&A Expenses	$38.1M-48.7%	$74.2M-22.7%	$96.1M-41.2%	$163.4M+6.0%	$154.2M-5.8%	$163.7M+4.6%	$156.5M+14.3%	$136.8M+13.6%	$120.4M+4.4%	$115.3M+9.2%	$105.6M+63.8%	$64.5M+66.1%	$38.8M+42.6%	$27.2M+22.6%	$22.2M
Operating Income	$39.0M-19.3%	$48.3M+197.8%	-$49.4M+75.9%	-$204.7M-238.5%	$147.8M-52.3%	$309.9M-17.5%	$375.4M+52.0%	$247.1M+37.7%	$179.4M+70.0%	$105.5M+8.7%	$97.0M-54.6%	$213.8M-4.2%	$223.3M+42.9%	$156.3M+89.2%	$82.6M
EBITDA	N/A	$70.8M+295.4%	-$36.2M+80.6%	-$186.4M-212.8%	$165.3M-49.5%	$327.4M-16.2%	$390.6M+49.8%	$260.8M+38.7%	$188.0M+64.5%	$114.3M+9.8%	$104.0M-52.0%	$216.9M-3.9%	$225.8M+42.2%	$158.8M+86.1%	$85.3M
Interest Expense	$117.4M-33.6%	$176.9M+12.0%	$158.0M-13.8%	$183.4M+41.6%	$129.5M+13.8%	$113.8M+14.6%	$99.2M+50.0%	$66.2M+121.6%	$29.9M+47.2%	$20.3M-28.1%	$28.2M+67.2%	$16.9M	$0	$0-100.0%	$26.4M
Income Tax	$54.9M-0.7%	$55.3M+498.1%	$9.2M+226.9%	-$7.3M-105.4%	$135.1M-10.2%	$150.5M+4.2%	$144.4M+27.7%	$113.1M+31.2%	$86.2M+64.2%	$52.5M+71.8%	$30.6M-63.5%	$83.7M+12.8%	$74.2M+26.5%	$58.6M+57.1%	$37.3M
Net Income	-$51.0M-226.7%	$40.3M+115.3%	-$263.4M+36.9%	-$417.3M-414.9%	-$81.0M-218.6%	$68.3M-6.4%	$73.0M+14.8%	$63.6M-12.8%	$73.0M+9.8%	$66.5M+37.0%	$48.5M-61.6%	$126.4M-19.5%	$157.0M+53.5%	$102.3M+100.0%	$51.1M
EPS (Basic)	-$0.45-218.4%	$0.38+115.6%	-$2.44+37.3%	-$3.89-418.7%	-$0.75-225.0%	$0.60+5.3%	$0.57+16.3%	$0.49-10.9%	$0.55+17.0%	$0.47+46.9%	$0.32-63.2%	$0.87-20.2%	$1.09+60.3%	$0.68+100.0%	$0.34
EPS (Diluted)	-$0.45-218.4%	$0.38+115.6%	-$2.44+37.3%	-$3.89-418.7%	-$0.75-225.0%	$0.60+5.3%	$0.57+18.7%	$0.48-9.4%	$0.53+17.8%	$0.45+55.2%	$0.29-65.9%	$0.85-21.3%	$1.08+58.8%	$0.68+106.1%	$0.33
Diluted Shares (Avg)	112M+5.2%	107M-1.1%	108M+0.5%	107M-0.3%	108M-5.7%	114M-11.6%	129M-1.9%	132M-4.4%	138M-6.0%	146M-17.3%	177M+18.5%	149M+3.3%	145M-4.4%	151M-2.6%	155M

Metric	Q4'2410-K	Q4'2310-K	Q4'2210-K	Q4'2110-K	Q4'2010-K	Q4'1910-K	Q4'1810-K	Q2'1810-Q

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

XIN Balance Sheet

XIN quarterly balance sheet

Metric	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K
Total Assets	$5.0B-5.8%	$5.3B-8.8%	$5.9B-9.2%	$6.4B-15.9%	$7.7B+3.3%	$7.4B-7.6%	$8.0B+25.8%	$6.4B+51.3%	$4.2B+18.9%	$3.5B+9.8%	$3.2B+35.7%	$2.4B+52.1%	$1.6B+12.6%	$1.4B+26.0%	$1.1B
Current Assets	N/A	$4.5B-8.1%	$4.9B+2.2%	$4.8B-14.6%	$5.6B-0.8%	$5.6B-15.6%	$6.7B+32.0%	$5.1B+29.0%	$3.9B+20.5%	$3.3B+6.3%	$3.1B+36.8%	$2.2B+47.1%	$1.5B+11.8%	$1.4B+26.9%	$1.1B
Cash & Equivalents	$94.4M-26.9%	$129.2M-54.4%	$283.1M-33.6%	$426.4M-54.0%	$926.8M+39.9%	$662.6M-1.7%	$674.1M-24.6%	$894.6M+54.7%	$578.2M+49.2%	$387.5M+175.8%	$140.5M-76.1%	$587.1M+18.3%	$496.2M+55.4%	$319.2M+49.6%	$213.3M
Short-Term Investments	$3.1M-42.7%	$5.4M-54.8%	$12.0M-85.9%	$85.2M+1294.4%	$6.1M+9.2%	$5.6M-33.7%	$8.4M-85.4%	$57.7M+46.9%	$39.3M+3058.4%	$1.2M-79.3%	$6.0M	$0	$0	$0	$0
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$3.2M-53.4%	$6.8M	N/A
Accounts Receivable	$42.1M-4.9%	$44.3M+35.8%	$32.6M-45.2%	$59.5M-38.1%	$96.1M-1.8%	$97.9M+52.7%	$64.1M-36.2%	$100.6M+207.5%	$32.7M-22.2%	$42.0M+172.0%	$15.5M+81.2%	$8.5M+177.2%	$3.1M-85.2%	$20.8M+492.6%	$3.5M
Long-Term Investments	$67.9M-8.0%	$73.8M-20.2%	$92.5M-86.1%	$667.2M-23.7%	$874.3M+42.5%	$613.6M+8.7%	$564.3M-32.0%	$829.8M+10541.4%	$7.8M-74.9%	$31.1M+12773.1%	$242K0.0%	$242K0.0%	$242K0.0%	$242K0.0%	$242K
Goodwill	N/A	N/A	N/A	N/A	N/A	$24.7M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$5.0B-5.0%	$5.2B-9.4%	$5.8B-4.4%	$6.0B-9.2%	$6.6B+0.2%	$6.6B-9.0%	$7.3B+36.8%	$5.3B+61.3%	$3.3B+26.4%	$2.6B+15.1%	$2.3B+58.9%	$1.4B+82.1%	$784.8M+4.0%	$754.9M+28.9%	$585.8M
Current Liabilities	$3.8B-8.3%	$4.1B-13.5%	$4.8B+0.3%	$4.8B+5.3%	$4.5B+1.2%	$4.5B-11.5%	$5.1B+38.0%	$3.7B+85.5%	$2.0B+20.0%	$1.7B+3.7%	$1.6B+97.3%	$807.4M+9.8%	$735.1M+17.1%	$627.9M+35.4%	$463.7M
Non-Current Liabilities	$1.2B+7.8%	$1.1B+10.8%	$974.5M-22.4%	$1.3B-40.4%	$2.1B-1.8%	$2.1B-3.3%	$2.2B+34.2%	$1.7B+25.0%	$1.3B+37.5%	$962.0M+41.8%	$678.3M+9.0%	$622.1M+1151.0%	$49.7M-60.8%	$127.0M+4.1%	$122.1M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$512.3M+61.1%	$318.1M+22.3%	$260.1M-22.9%	$337.2M+91.5%	$176.1M+10.0%	$160.0M-21.0%	$202.6M	N/A
Total Equity	-$104.2M-208.9%	-$33.7M+51.7%	-$69.9M-127.5%	$254.1M-61.8%	$665.5M-3.6%	$690.3M+1.5%	$680.4M-31.5%	$992.6M+10.3%	$900.3M-3.8%	$936.0M-2.6%	$960.6M+0.8%	$952.6M+21.9%	$781.5M+23.1%	$634.6M+22.6%	$517.8M
Retained Earnings	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$151.6M+680.7%	$19.4M+128.1%	-$69.2M

Metric	Q4'2410-K	Q4'2310-K	Q4'2210-K	Q4'2110-K	Q4'2010-K	Q4'1910-K	Q4'1810-K	Q2'1810-Q
Total Assets	$5.0B-5.8%	$5.3B-8.8%	$5.9B-9.2%	$6.4B-15.9%	$7.7B+3.3%	$7.4B-7.6%	$8.0B+25.8%	$8.1B+66.1%
Current Assets	N/A	$4.5B-8.1%	$4.9B+2.2%	$4.8B-14.6%	$5.6B-0.8%	$5.6B-15.6%	$6.7B+32.0%	$6.6B+45.7%
Cash & Equivalents	$94.4M-26.9%	$129.2M-54.4%	$283.1M-33.6%	$426.4M-54.0%	$926.8M+39.9%	$662.6M-1.7%	$674.1M-24.6%	$1.1B+11.9%
Short-Term Investments	$3.1M-42.7%	$5.4M-54.8%	$12.0M-85.9%	$85.2M+1294.4%	$6.1M+9.2%	$5.6M-33.7%	$8.4M-85.4%	$99.2M+99.7%
Accounts Receivable	$42.1M-4.9%	$44.3M+35.8%	$32.6M-45.2%	$59.5M-38.1%	$96.1M-1.8%	$97.9M+52.7%	$64.1M-36.2%	$37.5M+35.6%
Long-Term Investments	$67.9M-8.0%	$73.8M-20.2%	$92.5M-86.1%	$667.2M-23.7%	$874.3M+42.5%	$613.6M+8.7%	$564.3M-32.0%	$842.5M+9159.8%
Goodwill	N/A	N/A	N/A	N/A	N/A	$24.7M	N/A	N/A
Total Liabilities	$5.0B-5.0%	$5.2B-9.4%	$5.8B-4.4%	$6.0B-9.2%	$6.6B+0.2%	$6.6B-9.0%	$7.3B+36.8%	$7.5B+88.6%
Current Liabilities	$3.8B-8.3%	$4.1B-13.5%	$4.8B+0.3%	$4.8B+5.3%	$4.5B+1.2%	$4.5B-11.5%	$5.1B+38.0%	$5.5B+141.4%
Non-Current Liabilities	$1.2B+7.8%	$1.1B+10.8%	$974.5M-22.4%	$1.3B-40.4%	$2.1B-1.8%	$2.1B-3.3%	$2.2B+34.2%	$1.9B+16.3%
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$775.9M+53.5%
Total Equity	-$104.2M-208.9%	-$33.7M+51.7%	-$69.9M-127.5%	$254.1M-61.8%	$665.5M-3.6%	$690.3M+1.5%	$680.4M-31.5%	$670.2M-27.0%

Not reported in any period shown, so not listed: Inventory, Retained Earnings.

XIN Cash Flow Statement

XIN quarterly cash flow statement

Metric	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K
Operating Cash Flow	$18.2M+106.7%	-$270.8M+48.9%	-$530.3M-491.0%	$135.6M-59.7%	$336.8M+23.7%	$272.3M+1288.8%	-$22.9M-116.4%	$139.7M+187.4%	-$159.9M-3425.4%	-$4.5M+99.5%	-$884.3M-314.5%	-$213.3M-216.7%	$182.7M-14.1%	$212.8M+313.9%	$51.4M
Depreciation & Amortization	N/A	$22.5M+70.9%	$13.2M-27.9%	$18.3M+4.4%	$17.5M-0.5%	$17.6M+16.2%	$15.1M+10.2%	$13.7M+58.0%	$8.7M-0.7%	$8.8M+25.1%	$7.0M+123.1%	$3.1M+24.8%	$2.5M+0.5%	$2.5M-8.7%	$2.7M
Stock-Based Compensation	$1.1M	$0-100.0%	$568K-83.4%	$3.4M-24.3%	$4.5M-19.8%	$5.6M+66.2%	$3.4M-30.9%	$4.9M-37.5%	$7.8M+107.4%	$3.8M+38.0%	$2.7M+539.3%	$428K-80.1%	$2.2M+23.6%	$1.7M-34.2%	$2.6M
Capital Expenditures	$590K+58.3%	$373K+1200.3%	$29K-98.6%	$2.1M+59.1%	$1.3M-76.5%	$5.5M-39.7%	$9.1M+64.1%	$5.6M+103.2%	$2.7M-93.0%	$39.1M+109.3%	$18.7M-81.3%	$100.1M+26574.9%	$375K-67.8%	$1.2M+18.6%	$981K
Free Cash Flow	$17.6M+106.5%	-$271.1M+48.9%	-$530.3M-497.1%	$133.6M-60.2%	$335.5M+25.8%	$266.7M+932.7%	-$32.0M-123.9%	$134.1M+182.5%	-$162.6M-272.5%	-$43.7M+95.2%	-$903.0M-188.1%	-$313.4M-271.9%	$182.3M-13.9%	$211.7M+319.6%	$50.4M
Investing Cash Flow	$10.0M+1000.1%	-$1.1M-100.2%	$513.9M+2356.5%	-$22.8M+78.1%	-$104.2M-142.1%	-$43.0M-224.5%	$34.6M+104.2%	-$827.2M-18614.7%	$4.5M+112.8%	-$35.0M	N/A	N/A	-$354K+69.6%	-$1.2M-113.8%	$8.4M
Financing Cash Flow	-$99.3M-109.9%	-$47.3M+21.7%	-$60.4M+91.1%	-$677.1M-256.2%	-$190.1M+31.7%	-$278.5M-46.9%	-$189.6M-116.4%	$1.2B+235.8%	$343.8M+12.3%	$306.3M	N/A	N/A	-$6.8M+94.3%	-$118.7M-1063.1%	-$10.2M
Dividends Paid	$3.4M	N/A	$4.7M+14.9%	$4.1M-71.6%	$14.3M-27.3%	$19.6M-23.7%	$25.7M-1.3%	$26.1M+27.0%	$20.5M+39.3%	$14.8M-3.5%	$15.3M+3.8%	$14.7M+67.9%	$8.8M+14.5%	$7.7M	$0
Share Buybacks	$441K-39.8%	$732K	N/A	N/A	$2.5M-90.5%	$26.1M+31.4%	$19.8M+41.2%	$14.1M-52.6%	$29.7M+786.4%	$3.3M-81.0%	$17.6M+205.4%	$5.8M+1.0%	$5.7M-28.3%	$8.0M	$0

Metric	Q4'2410-K	Q4'2310-K	Q4'2210-K	Q4'2110-K	Q4'2010-K	Q4'1910-K	Q4'1810-K	Q2'1810-Q

Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.

XIN Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

XIN quarterly financial ratios

Metric	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K
Gross Margin	16.0%-0.4pp	16.5%+8.9pp	7.6%+3.1pp	4.4%-12.3pp	16.8%-5.8pp	22.6%-5.2pp	27.8%+4.5pp	23.3%+0.3pp	22.9%-0.5pp	23.4%-2.9pp	26.3%-7.0pp	33.3%+2.7pp	30.6%+1.6pp	29.0%+3.4pp	25.7%
Operating Margin	7.6%+1.6pp	6.0%+11.2pp	-5.2%+8.1pp	-13.3%-21.8pp	8.5%-4.0pp	12.5%-4.5pp	16.9%+4.4pp	12.5%+1.0pp	11.5%+2.4pp	9.1%-1.5pp	10.5%-13.3pp	23.8%-0.6pp	24.4%+1.7pp	22.7%+4.4pp	18.4%
Net Margin	-9.9%-14.9pp	5.0%+32.7pp	-27.7%-0.6pp	-27.2%-22.5pp	-4.6%-7.4pp	2.8%-0.5pp	3.3%+0.1pp	3.2%-1.4pp	4.7%-1.0pp	5.7%+0.4pp	5.3%-8.8pp	14.1%-3.1pp	17.2%+2.3pp	14.9%+3.5pp	11.4%
Return on Equity	N/A	N/A	N/A	-164.2%-152.1pp	-12.2%-22.1pp	9.9%-0.8pp	10.7%+4.3pp	6.4%-1.7pp	8.1%+1.0pp	7.1%+2.0pp	5.1%-8.2pp	13.3%-6.8pp	20.1%+4.0pp	16.1%+6.2pp	9.9%
Return on Assets	-1.0%-1.8pp	0.8%+5.3pp	-4.5%+2.0pp	-6.5%-5.4pp	-1.1%-2.0pp	0.9%0.0pp	0.9%-0.1pp	1.0%-0.7pp	1.7%-0.1pp	1.9%+0.4pp	1.5%-3.8pp	5.3%-4.7pp	10.0%+2.7pp	7.4%+2.7pp	4.6%
Current Ratio	N/A	1.08+0.1x	1.020.0x	1.00-0.2x	1.230.0x	1.26-0.1x	1.32-0.1x	1.38-0.6x	1.980.0x	1.980.0x	1.93-0.9x	2.78+0.7x	2.08-0.1x	2.17-0.1x	2.32
Debt-to-Equity	N/A	N/A	N/A	23.74+13.8x	9.98+0.4x	9.60-1.1x	10.71+10.2x	0.52+0.2x	0.35+0.1x	0.28-0.1x	0.35+0.2x	0.180.0x	0.20-0.1x	0.32-0.8x	1.13
Asset Turnover	0.100.0x	0.150.0x	0.16-0.1x	0.240.0x	0.23-0.1x	0.33+0.1x	0.280.0x	0.31-0.1x	0.370.0x	0.330.0x	0.28-0.1x	0.38-0.2x	0.58+0.1x	0.49+0.1x	0.41
FCF Margin	3.4%+37.1pp	-33.7%+22.1pp	-55.8%-64.5pp	8.7%-10.5pp	19.2%+8.5pp	10.7%+12.2pp	-1.4%-8.2pp	6.8%+17.2pp	-10.4%-6.7pp	-3.8%+94.4pp	-98.2%-63.3pp	-34.9%-54.8pp	19.9%-10.9pp	30.8%+19.6pp	11.2%

Metric	Q4'2410-K	Q4'2310-K	Q4'2210-K	Q4'2110-K	Q4'2010-K	Q4'1910-K	Q4'1810-K	Q2'1810-Q
Current Ratio	N/A	1.08+0.1x	1.020.0x	1.00-0.2x	1.230.0x	1.26-0.1x	1.32-0.1x	1.20-0.8x
Debt-to-Equity	N/A	N/A	N/A	23.74+13.8x	9.98+0.4x	9.60-1.1x	10.71+10.2x	1.16+0.6x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.

Note: Shareholder equity is negative (-$104.2M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Xinyuan Real Estate Co. LTD. American XIN	FY2024	$514.7M	-$51.0M	-9.9%	$13.5M	17/100
Safe and Green Development Corporation SGD	FY2025	$8.2M	-$16.0M	N/A	$2.2M	25/100
Wetouch Technology Inc. WETH	FY2025	$45.1M	$7.2M	15.9%	$13.8M	77/100
JFB Construction Holdings JFB	FY2025	$30.5M	-$5.3M	-17.3%	$100.0M	55/100
La Rosa Holding Corp. LRHC	FY2025	$68.5M	-$30.5M	-44.6%	$8.1M	4/100

Where Xinyuan Real Estate Co. LTD. American Ranks

Frequently Asked Questions

What is Xinyuan Real Estate Co. LTD. American's annual revenue?

Xinyuan Real Estate Co. LTD. American (XIN) reported $514.7M in total revenue for fiscal year 2024. This represents a -36.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Xinyuan Real Estate Co. LTD. American's revenue growing?

Xinyuan Real Estate Co. LTD. American (XIN) revenue declined by 36.1% year-over-year, from $805.0M to $514.7M in fiscal year 2024.

Is Xinyuan Real Estate Co. LTD. American profitable?

No, Xinyuan Real Estate Co. LTD. American (XIN) reported a net income of -$51.0M in fiscal year 2024, with a net profit margin of -9.9%.

What is Xinyuan Real Estate Co. LTD. American's gross margin?

Xinyuan Real Estate Co. LTD. American (XIN) had a gross margin of 16.0% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.

What is Xinyuan Real Estate Co. LTD. American's operating margin?

Xinyuan Real Estate Co. LTD. American (XIN) had an operating margin of 7.6% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

What is Xinyuan Real Estate Co. LTD. American's net profit margin?

Xinyuan Real Estate Co. LTD. American (XIN) had a net profit margin of -9.9% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

What is Xinyuan Real Estate Co. LTD. American's free cash flow?

Xinyuan Real Estate Co. LTD. American (XIN) generated $17.6M in free cash flow during fiscal year 2024. This represents a 106.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Xinyuan Real Estate Co. LTD. American's operating cash flow?

Xinyuan Real Estate Co. LTD. American (XIN) generated $18.2M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are Xinyuan Real Estate Co. LTD. American's total assets?

Xinyuan Real Estate Co. LTD. American (XIN) had $5.0B in total assets as of fiscal year 2024, including both current and long-term assets.

What are Xinyuan Real Estate Co. LTD. American's capital expenditures?

Xinyuan Real Estate Co. LTD. American (XIN) invested $590K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

Does Xinyuan Real Estate Co. LTD. American buy back shares?

Yes, Xinyuan Real Estate Co. LTD. American (XIN) spent $441K on share buybacks during fiscal year 2024, returning capital to shareholders by reducing shares outstanding.

How many shares does Xinyuan Real Estate Co. LTD. American have outstanding?

Xinyuan Real Estate Co. LTD. American (XIN) had 113M shares outstanding as of fiscal year 2024.

What is Xinyuan Real Estate Co. LTD. American's return on assets (ROA)?

Xinyuan Real Estate Co. LTD. American (XIN) had a return on assets of -1.0% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

Why is Xinyuan Real Estate Co. LTD. American's debt-to-equity ratio negative or not reported?

Xinyuan Real Estate Co. LTD. American (XIN) has negative shareholder equity of -$104.2M as of fiscal year 2024, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is Xinyuan Real Estate Co. LTD. American's Piotroski F-Score?

Xinyuan Real Estate Co. LTD. American (XIN) has a Piotroski F-Score of 2 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Xinyuan Real Estate Co. LTD. American's earnings high quality?

Xinyuan Real Estate Co. LTD. American (XIN) reported a net loss of $51.0M while generating $18.2M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Xinyuan Real Estate Co. LTD. American cover its interest payments?

Xinyuan Real Estate Co. LTD. American (XIN) has an interest coverage ratio of 0.33x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Xinyuan Real Estate Co. LTD. American?

Xinyuan Real Estate Co. LTD. American (XIN) scores 17 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.